The University of Chicago Header Logo

Connection

Luciana Molinero to Survival Rate

Back to Details
This is a "connection" page, showing publications Luciana Molinero has written about Survival Rate.
Luciana Molinero
Connection Strength
0.032
Survival Rate
  1. Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 2020 01; 21(1):44-59.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.